Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab

BACKGROUND: Pemphigus vulgaris (PV) is a blistering, life-threatening autoimmune disease. Ethylenediaminetetraacetic acid (EDTA)-treated desmoglein (Dsg) enzyme-linked immunosorbent assay (ELISA) has recently been suggested to detect nonpathogenic antibodies. Rituximab (RTX) is now considered a firs...

全面介紹

Na minha lista:
書目詳細資料
發表在:Int J Womens Dermatol
Main Authors: Alaeen, Hoorieh, Toosi, Roja, Mahmoudi, Hamidreza, Balighi, Kamran, Tavakolpour, Soheil, Teimoupour, Amir, Daneshpazhooh, Maryam
格式: Artigo
語言:Inglês
出版: Elsevier 2019
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6938821/
https://ncbi.nlm.nih.gov/pubmed/31909160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijwd.2019.05.008
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍